876290-12-9Relevant academic research and scientific papers
Synthesis and photophysical properties of biphenyl and terphenyl arylene-ethynylene macrocycles
Korich, Andrew L.,McBee, Ian A.,Bennion, Jonathan C.,Gifford, Jenna I.,Hughes, Thomas S.
, p. 1594 - 1610 (2014)
A series of single-walled carbon nanotube precursors, C3h- symmetric cyclotri(ethynylene)(biphenyl-2,4′-diyl) and cyclotri(ethynylene)(p-terphenyl-2,4″-diyl), have been prepared by a linear stepwise oligomerization-cyclization route and by stat
DINAPHTHOTHIOPHENE COMPOUND, COMPOSITION FOR ORGANIC THIN FILM TRANSISTOR INCLUDING THE DINAPHTHOTHIOPHENE AND ORGANIC THIN FILM TRANSISTOR USING THE SAME
-
Paragraph 0105; 0106, (2018/10/31)
PROBLEM TO BE SOLVED: To provide a dinaphthothiophene compound capable of producing an organic thin film transistor operating at a high mobility. SOLUTION: Provided is a dinaphthothiophene compound represented by formula (A), in which at least one among R1 to R12 denotes a substitutional group represented by formula (1); and Y denotes a 4 to 30C substituted or unsubstituted alkyl group. COPYRIGHT: (C)2015,JPO&INPIT
ORGANIC COMPOUNDS
-
Page/Page column 42, (2014/05/24)
Novel benzofuran derivatives are disclosed. The derivatives have S1P1 receptor activity and/or disease modifying activity and find use in the treatment of conditions or diseases associated with the immune, vascular and nervous systems in animals and/or humans
S1P RECEPTORS MODULATORS AND THEIR USE THEREOF
-
Page/Page column 105, (2010/04/30)
The invention relates to novel compounds that have S1P receptor modulating activity. Further, the invention relates to a pharmaceutical comprising at least one compound of the invention for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression, for example, autoimmune response. A further aspect of the invention relates to the use of a pharmaceutical comprising at least one compound of the invention for the manufacture of a medicament for the treatment of diseases and/or conditions caused by or associated with inappropriate S1P receptor modulating activity or expression such as autoimmune response.
Dispirofluorene-indenofluorene (DSFIF): Synthesis, electrochemical, and optical properties of a promising new family of luminescent materials
Horhant, David,Liang, Jing-Jing,Virboul, Morgane,Poriel, Cyril,Alcaraz, Gilles,Rault-Berthelot, Joelle
, p. 257 - 260 (2007/10/03)
A series of new dispiro[fluorene-9′,6,9″,12-indeno[1,2b] fluorenes] (DSFIFs) that combine indenofluorene (IF) and spirobifluorene (SBF) architectural specificities have been prepared. Their anodic oxidations lead to the formation of nonsoluble transparent
